SCHEMBL13680420

SCHEMBL13680420

Cc1ccccc1Oc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.58
SLC6A3 Q01959 2/20 0.58
SLC6A2 P23975 1/20 0.58
AR P10275 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SCN8A Q9UQD0 2/20 0.44
SCN10A Q9Y5Y9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690257 0.84 ALDH1A1 (0.59) SLC6A4ARSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL3748487 0.81 AR (0.54) SLC6A4ARSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL5990326 0.80 SCN8A (0.49) SLC6A4SLC6A3SLC6A2ARSMN1; SMN2
SCHEMBL3755350 0.80 ALDH1A1 (0.53) SLC6A4SLC6A3SLC6A2ARSMN1; SMN2
SCHEMBL257293 0.80 HSD11B1 (0.44) SLC6A4SLC6A3SLC6A2ARSMN1; SMN2
SCHEMBL5990167 0.79 AR (0.49) SLC6A4SLC6A3SLC6A2ARALDH1A1
SCHEMBL22199038 0.79 GPR3 (0.47) SLC6A4SLC6A3SLC6A2ARSCN8A
SCHEMBL12301144 0.78 RXRA (0.54) SLC6A4SLC6A3SLC6A2SMN1; SMN2NPC1
SCHEMBL172615 0.78 HTR2A (0.55) SLC6A4ARSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL28816731 0.78 LTA4H (0.55) SLC6A4SLC6A2ARSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582664-B2 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics SANOFI-AVENTIS (FR) 2009-09-01 US disclosed